Apixaban and Bleeding time prolonged - a phase IV clinical study of FDA data

Summary:

Bleeding time prolonged is reported as a side effect among people who take Apixaban (apixaban), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Sertraline, and have Deep venous thrombosis.

The phase IV clinical study analyzes which people have Bleeding time prolonged when taking Apixaban. It is created by eHealthMe based on reports of 60,044 people who have side effects when taking Apixaban from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

What is Bleeding time prolonged?

Bleeding time prolonged is found to be associated with 221 drugs and 380 conditions by eHealthMe. Check the latest studies of Bleeding time prolonged.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

60,044 people reported to have side effects when taking Apixaban.
Among them, 47 people (0.08%) have Bleeding time prolonged.

Could Apixaban cause Bleeding time prolonged?

Among these 47 people:

How long have people been on Apixaban when they have Bleeding time prolonged? *

What is the gender of people who have Bleeding time prolonged when taking Apixaban? *

female: 23.81 %
male: 76.19 %

What is the age of people who have Bleeding time prolonged when taking Apixaban? *

What are other drugs people take besides Apixaban? *

What are other side effects people have besides Bleeding time prolonged? *

Sepsis (a severe blood infection that can lead to organ failure and death): 25 people, 53.19%
Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 19 people, 40.43%
Heart Attack: 19 people, 40.43%
Liver Function Test Abnormal: 19 people, 40.43%
Confusional State: 19 people, 40.43%
Head Injury: 15 people, 31.91%
Dehydration (dryness resulting from the removal of water): 12 people, 25.53%
Dental Caries: 8 people, 17.02%
Hemiparesis (weakness on one side of the body): 8 people, 17.02%
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery): 8 people, 17.02%

What are the existing conditions these people have? *

Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 20 people, 42.55%
Pneumonia: 19 people, 40.43%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 12.77%
Primary Myelofibrosis (primary disorder of the bone marrow): 6 people, 12.77%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 6 people, 12.77%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 2.13%
Spinal Osteoarthritis (joint cartilage loss in spine): 1 person, 2.13%
Osteoporosis (bones weak and more likely to break): 1 person, 2.13%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 2.13%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and have Bleeding time prolonged?

- Check whether Bleeding time prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apixaban:

Apixaban (60,351 reports)

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding time prolonged:

Bleeding time prolonged (221 drugs)

Browse all the conditions that are associated with Bleeding time prolonged:

Bleeding time prolonged (380 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Apixaban) and Apixaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.